next flag, page-31

I've read elsewhere that Biotech companies typically burn through a lot of cash during the development phase of a new product. I am interested to hear people's opinion regarding BTA and the decision to give back 20 million in dividends to shareholders. Okay, so Relenza royalties will hopefully continue to cover expenses for a while to come, but I'm wondering if my 11cps dividend could be better spent in other areas such as product development or possible takeovers.